DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on June 6, 2007; DOI: 10.1124/dmd.107.015008


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.015008v1
35/9/1564    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, Y.
Right arrow Articles by Yao, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, Y.
Right arrow Articles by Yao, X.


Received for publication February 2, 2007.
Revised May 31, 2007.
Accepted for publication June 5, 2007.

Isolation and Identification of Phase 1 Metabolites of Demethoxycurcumin in Rats

Yongchi Zeng 1, Feng Qiu 1*, Yuan Liu 1, Gexia Qu 1, Xinsheng Yao 1

1 Shenyang Pharmaceutical University

* Address correspondence to: E-mail: fengqiu20070118{at}163.com

Abstract

Curcuminoids are a safe natural food coloring additive with anti-inflammatory, antioxidant and anticarcinogenic activities. Although demethoxycurcumin is one of the major bioactive constituents of curcuminoids, knowledge about its metabolic fate is scant. In the present study, four new metabolites: 5-dehydroxy-hexahydro-demethoxycurcumin-A (M-1), 5-dehydroxy-hexahydro-demethoxycurcumin-B (M-2), 5-dehydroxy-octahydro-demethoxycurcumin-A (M-3) and 5-dehydroxy-octahydro-demethoxycurcumin-B (M-4) were isolated from feces of male Wistar-derived rats and from urine, three new metabolites: 5-O-methyl-hexahydro-demethoxycurcumin-A (M-7), 5-O-methyl-hexahydro-demethoxycurcumin-B (M-8), and 5-dehydroxy-dihydro-demethoxycurcumin-B (M-9) and two known metabolites: hexahydro-demethoxycurcumin-A (M-5), hexahydro-demethoxycurcumin-B (M-6) were isolated. Their structures were established by chemical and spectral methods. All of them were reductive metabolites. Possibly of greater importance is that they occurred as pairs of isomers with a methoxyl group substituted on a different benzene ring. This finding in the metabolism of curcuminoids is reported here for the first. In addition, the 5-dehydroxy or 5-O-methylated metabolites are also novel finding. The fact that the metabolites occurred as pairs of the isomers suggests that demethoxycurcumin possibly undergoes tautomerization between 3-keto-5-enol (form A) and 3-keto-5-enol (form B) (Fig. 1) in rats. On the basis of the metabolite profiles, metabolic pathways of demethxoycurcumin in rats are proposed.


Key words: metabolite identification, structure elucidation


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
C. Jia, H. Shi, W. Jin, K. Zhang, Y. Jiang, M. Zhao, and P. Tu
Metabolism of Echinacoside, a Good Antioxidant, in Rats: Isolation and Identification of Its Biliary Metabolites
Drug Metab. Dispos., February 1, 2009; 37(2): 431 - 438.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.